I-ELCAP Publications

  • Henschke CI, Yip R, Yankelevitz DF, Smith JP for the I-ELCAP Investigators. CT screening for lung cancer: update of the definition of positive test result and its implications. Annals of Internal Medicine 2013; 158: 246-252
  • Austin JJ, Yip R, D-Souza BM, Yankelevitz DF, Henschke CI for the I-ELCAP Investigators.. Small-cell carcinoma of the lung detected by CT screening: stage distribution and curability. Radiology 2012; 76-339-343;
  • Farooqi AO, Cham M, Zhang L, Beasley MB, Austin AJM, Miller A, Zulueta JJ, Roberts H, Cole E, Kao S, Thorsen MK, Smith JP, Yip R, Yankelevitz DF, Henschke CI for the I-ELCAP Investigators.. Lung Cancer Associated with Cystic Airspaces. . AJR 2012: 1999; 781-785
  • Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, Smith JP, Libby DM, Pasmantier MW, Miettinen OS.. Lung Cancers Diagnosed by Annual CT Screening: Volume Doubling Times. Radiology 2012; 76: 339-343
  • Henschke CI, Boffetta P, Gorlova O, Yip R, Delancey JO, and Foy M. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011; 71: 328-32
  • Huang Y, Xu D, Jirapatnakul A, Reeves AP, Farooqi A, Zhang L, Giunta S, Zulueta J, Aye R, Miller A, Mendelson DS, Aylesworth C, Sheppard B, Klingler K, Yankelevitz DF, and Henschke CI and I-ELCAP Investigators. CT- and computer-based features of small hamartomas. Clin Imaging 2011; 35: 116-22
  • Foy M, Yip R, Chen X, Kimmel M, Gorlova OY, and Henschke CI. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer 2011; 117: 2703-8
  • Shemesh J, Henschke CI, Shaham D, Yip R, Farooqi AO, Cham MD, McCauley DI, Chen M, Smith JP, Libby DM, Pasmantier MW, and Yankelevitz DF. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 2010; 257: 541-8
  • Zhang L, Yankelevitz DF, Henschke CI, Reeves AP, Vazquez MF, and Carter D. . Variation in vascular distribution in small lung cancers. Lung Cancer 2010; 68: 389-93
  • Zhang L, Yankelevitz DF, Henschke CI, Jirapatnakul AC, Reeves AP, and Carter D. . Zone of transition: a potential source of error in tumor volume estimation. Radiology 2010; 256: 633-9
  • Anderson CM, Yip R, Henschke CI, Yankelevitz DF, Ostroff JS, and Burns DM . Smoking cessation and relapse during a lung cancer screening program. Cancer Epidemio Biomarkers Prev 2009; 18: 3476-83.
  • Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Huang Y, Zhang L, Yip R, Yankelevitz DF, and Henschke CI. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. . Lung Cancer 2009; 64; 148-54
  • Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yip R, Yankelevitz DF, and Henschke CI. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007; 56: 193-9
  • NY-ELCAP Investigators. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 2007; 243: 239-49
  • International Early Lung Cancer Action Program Investigators. CT screening for lung cancer: individualizing the benefit of the screening. European Respiratory Journal 2007; 30: 843-847
  • Henschke CI, Yankelevitz DF, and Miettinen OS. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 2006; 166: 321-5
  • Henschke CI, Yip R, Yankelevitz DF, and Miettinen OS. Computed tomography screening for lung cancer: prospects of surviving competing causes of death. Clin Lung Cancer 2006; 7: 323-5
  • Henschke CI, Lee IJ, Wu N, Farooqi A, Khan A, Yankelevitz D, and Altorki NK. CT screening for lung cancer: prevalence and incidence of mediastinal masses. Radiology 2006; 239: 586-90
  • Henschke CI, Shaham D, Yankelevitz DF, Kramer A, Kostis WJ, Reeves AP, Vazquez M, Koizumi J, and Miettinen OS. CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imaging 2006; 30: 11-5
  • Libby DM, Wu N, Lee IJ, Farooqi A, Smith JP, Pasmantier MW, McCauley D, Yankelevitz DF, and Henschke CI. CT screening for lung cancer: the value of short-term CT follow-up. Chest 2006; 129: 1039-42.
  • Shemesh J, Henschke CI, Farooqi A, Yip R, Yankelevitz DF, Shaham D, and Miettinen OS. Frequency of coronary artery calcification on low-dose computed tomography screening for lung cancer. Clin Imaging 2006; 30: 181-5
  • Reeves AP, Chan AB, Yankelevitz DF, Henschke CI, Kressler B, and Kostis WJ. On measuring the change in size of pulmonary nodules. IEEE Trans Med Imaging 2006; 25: 435-50
  • Flieder DB, Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yankelevitz DF, and Henschke CI. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006; 30: 606-13
  • Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, and Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. New England Journal of Medicine 2006; 355: 1763-71
  • Henschke CI, Yankelevitz DF, and Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. Journal of the American Medical Association 2006; 296: 180-4

Pages